Monte Rosa Therapeutics, Inc. (GLUE)
13.84
-0.54
(-3.76%)
USD |
NASDAQ |
Sep 04, 16:00
13.97
+0.13
(+0.94%)
After-Hours: 20:00
Monte Rosa Therapeutics Cash and Short Term Investments (Annual) : 377.10M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 377.10M |
| December 31, 2024 | 372.15M |
| December 31, 2023 | 232.41M |
| December 31, 2022 | 263.79M |
| Date | Value |
|---|---|
| December 31, 2021 | 346.07M |
| December 31, 2020 | 41.70M |
| December 31, 2019 | 9.245M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Nurix Therapeutics, Inc. | 592.94M |
| Gilead Sciences, Inc. | 9.613B |
| Ironwood Pharmaceuticals, Inc. | 215.46M |
| Capricor Therapeutics, Inc. | 318.13M |
| Cue Biopharma, Inc. | 27.14M |